| Sildenafil inhibits hypoxia-induced pulmonary hypertension L Zhao, NA Mason, NW Morrell, B Kojonazarov, A Sadykov, A Maripov, ... Circulation 104 (4), 424-428, 2001 | 636 | 2001 |
| Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension R Savai, HM Al-Tamari, D Sedding, B Kojonazarov, C Muecke, R Teske, ... Nature medicine 20 (11), 1289-1300, 2014 | 271 | 2014 |
| Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension SS Pullamsetti, C Doebele, A Fischer, R Savai, B Kojonazarov, BK Dahal, ... American journal of respiratory and critical care medicine 185 (4), 409-419, 2012 | 257 | 2012 |
| Characterization of high-altitude pulmonary hypertension in the Kyrgyz: association with angiotensin-converting enzyme genotype AA Aldashev, AS Sarybaev, AS Sydykov, BB Kalmyrzaev, EV Kim, ... American journal of respiratory and critical care medicine 166 (10), 1396-1402, 2002 | 160 | 2002 |
| Phosphodiesterase type 5 and high altitude pulmonary hypertension AA Aldashev, BK Kojonazarov, TA Amatov, TM Sooronbaev, ... Thorax 60 (8), 683-687, 2005 | 154 | 2005 |
| The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats M Lang, B Kojonazarov, X Tian, A Kalymbetov, N Weissmann, ... Public Library of Science 7 (8), e43433, 2012 | 139 | 2012 |
| Cystathionine γ lyase sulfhydrates the RNA binding protein human antigen R to preserve endothelial cell function and delay atherogenesis SI Bibli, J Hu, F Sigala, I Wittig, J Heidler, S Zukunft, DI Tsilimigras, ... Circulation 139 (1), 101-114, 2019 | 115 | 2019 |
| Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension. S Dabral, X Tian, B Kojonazarov, R Savai, HA Ghofrani, N Weissmann, ... European Respiratory Journal 48 (4), 1137-1149, 2016 | 108 | 2016 |
| 5-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failure W Janssen, Y Schymura, T Novoyatleva, B Kojonazarov, M Boehm, ... BioMed research international 2015, 2015 | 103 | 2015 |
| ASK1 inhibition halts disease progression in preclinical models of pulmonary arterial hypertension GR Budas, M Boehm, B Kojonazarov, G Viswanathan, X Tian, S Veeroju, ... American journal of respiratory and critical care medicine 197 (3), 373-385, 2018 | 90 | 2018 |
| p38 MAPK inhibition improves heart function in pressure-loaded right ventricular hypertrophy B Kojonazarov, T Novoyatleva, M Boehm, C Happe, Z Sibinska, X Tian, ... American journal of respiratory cell and molecular biology 57 (5), 603-614, 2017 | 90 | 2017 |
| Mitochondrial hyperpolarization in pulmonary vascular remodeling. Mitochondrial uncoupling protein deficiency as disease model O Pak, N Sommer, T Hoeres, A Bakr, S Waisbrod, A Sydykov, D Haag, ... American journal of respiratory cell and molecular biology 49 (3), 358-367, 2013 | 85 | 2013 |
| Lung cancer–associated pulmonary hypertension: Role of microenvironmental inflammation based on tumor cell–immune cell cross-talk S Pullamsetti, B Kojonazarov, S Storn, H Gall, Y Salazar, J Wolf, A Weigert, ... Science Translational Medicine 9 (416), eaai9048, 2017 | 84 | 2017 |
| PAR-2 inhibition reverses experimental pulmonary hypertension G Kwapiszewska, P Markart, BK Dahal, B Kojonazarov, LM Marsh, ... Circulation research 110 (9), 1179-1191, 2012 | 83 | 2012 |
| Amplified canonical transforming growth factor-β signalling via heat shock protein 90 in pulmonary fibrosis Z Sibinska, X Tian, M Korfei, B Kojonazarov, JS Kolb, W Klepetko, ... European Respiratory Journal 49 (2), 2017 | 80 | 2017 |
| Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension A Weiss, MC Neubauer, D Yerabolu, B Kojonazarov, BC Schlueter, ... Nature communications 10 (1), 2204, 2019 | 75 | 2019 |
| miR-223–IGF-IR signalling in hypoxia-and load-induced right-ventricular failure: a novel therapeutic approach L Shi, B Kojonazarov, A Elgheznawy, R Popp, BK Dahal, M Böhm, ... Cardiovascular research 111 (3), 184-193, 2016 | 69 | 2016 |
| Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension M Boehm, N Arnold, A Braithwaite, J Pickworth, C Lu, T Novoyatleva, ... BMC Pulmonary Medicine 18, 1-8, 2018 | 62 | 2018 |
| Effects of fasudil in patients with high-altitude pulmonary hypertension B Kojonazarov, A Myrzaakhmatova, T Sooronbaev, T Ishizaki, A Aldashev European Respiratory Journal 39 (2), 496-498, 2012 | 61 | 2012 |
| Noninvasive and invasive evaluation of pulmonary arterial pressure in highlanders BK Kojonazarov, BZ Imanov, TA Amatov, MM Mirrakhimov, R Naeije, ... European Respiratory Journal 29 (2), 352-356, 2007 | 53 | 2007 |
